{"disease":{"id":"seasonal-allergic-rhinitis","name":"Seasonal allergic rhinitis","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":40,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"omalizumab","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xolair","generic_name":"omalizumab","company_name":"Roche","drug_phase":"marketed","molecular_target":"Ig epsilon chain C region","drug_class":"Anti-IgE [EPC]","quality_score":52,"revenue":"3200","mechanism":null},{"drug_id":"dexamethasone-phosphate","indication_name":"Seasonal or perennial allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dexamethasone Sodium Phosphate","generic_name":"dexamethasone phosphate","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Androgen receptor, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"desloratadine-and-pseudoephedrine","indication_name":"Seasonal Allergic Rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Desloratadine and pseudoephedrine","company_name":"Dr. Reddy's Laboratories Limited","drug_phase":"marketed","molecular_target":"H1 receptor","drug_class":"Histamine-1 Receptor Antagonist [EPC]","quality_score":47,"revenue":null,"mechanism":"Desloratadine blocks histamine H1 receptors, reducing allergy symptoms; pseudoephedrine relieves nasal congestion by constricting blood vessels."},{"drug_id":"doxylamin","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Doxylamin","company_name":"St. Petersburg Bekhterev Research Psychoneurological Institute","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"dexbrompheniramine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Drixoral","generic_name":"DEXBROMPHENIRAMINE","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"dexbrompheniramine","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"mepyramine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pyrilamine","generic_name":"mepyramine","company_name":"Impax Labs","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Central Nervous System Stimulant [EPC]","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"acrivastine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Semprex-D","generic_name":"ACRIVASTINE","company_name":"Auxilium Pharms Inc","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Histamine-1 Receptor Antagonist","quality_score":34,"revenue":null,"mechanism":""},{"drug_id":"phenylpropanolamine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Propadrine","generic_name":"PHENYLPROPANOLAMINE","company_name":"Alpharma Us Pharms","drug_phase":"marketed","molecular_target":"Sodium-dependent noradrenaline transporter","drug_class":"Indirectly Acting Sympathomimetic Amines","quality_score":36,"revenue":null,"mechanism":""},{"drug_id":"chlorpheniramine-maleate","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tussionex Pennkinetic","generic_name":"CHLORPHENIRAMINE MALEATE","company_name":"Bayer","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Histamine-1 Receptor Antagonist","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"levocetirizine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xyzal","generic_name":"LEVOCETIRIZINE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Histamine-1 Receptor Antagonist","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"alvesco","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Omnaris","generic_name":"Alvesco","company_name":"Takeda Gmbh","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"ciclesonide","quality_score":10,"revenue":null,"mechanism":"Omnaris works by activating the glucocorticoid receptor to reduce inflammation in the airways."},{"drug_id":"fexofenadine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Allegra","generic_name":"fexofenadine","company_name":"Generic (originally Hoechst Marion Roussel/Sanofi)","drug_phase":"marketed","molecular_target":"Solute carrier organic anion transporter family member 1A2, Multidrug resistance protein 1, Histamine H1 receptor","drug_class":"Second-generation antihistamine","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"doxylamine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Unisom","generic_name":"DOXYLAMINE","company_name":"Chattem","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Antihistamine","quality_score":34,"revenue":null,"mechanism":""},{"drug_id":"ciclesonide","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Omnaris","generic_name":"CICLESONIDE","company_name":"Covis","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"ciclesonide","quality_score":10,"revenue":null,"mechanism":"Omnaris works by binding to the glucocorticoid receptor, which then reduces inflammation in the airways."},{"drug_id":"cyclizine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Marezine","generic_name":"CYCLIZINE","company_name":"GSK","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"cyclizine","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"terfenadine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Seldane","generic_name":"TERFENADINE","company_name":"","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"High Risk QT Prolonging Agents","quality_score":32,"revenue":null,"mechanism":""},{"drug_id":"phenylephrine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sudafed PE","generic_name":"phenylephrine","company_name":"Generic (multiple manufacturers)","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor","drug_class":"Alpha-1 adrenergic agonist (decongestant/vasopressor)","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"quifenadine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Phencarol","generic_name":"QUIFENADINE","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"quifenadine","quality_score":null,"revenue":null,"mechanism":"Phencarol works by blocking the action of histamine, a chemical released by the body during an allergic reaction."},{"drug_id":"chlorcyclizine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Perazyl","generic_name":"CHLORCYCLIZINE","company_name":"","drug_phase":"marketed","molecular_target":"Apoptosis regulator Bcl-2","drug_class":"chlorcyclizine","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"benadryl","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Benadryl","company_name":"Brooke Army Medical Center","drug_phase":"discontinued","molecular_target":"Histamine H4 receptor, Solute carrier family 22 member 2, 5-hydroxytryptamine receptor 2A","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"phenylephrine-bitartrate","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Phenergan Vc W/ Codeine","generic_name":"PHENYLEPHRINE BITARTRATE","company_name":"ANI Pharmaceuticals","drug_phase":"marketed","molecular_target":"Alpha-1B adrenergic receptor","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"diphenhydramine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Benadryl","generic_name":"diphenhydramine","company_name":"Johnson & Johnson (McNeil Consumer Healthcare)","drug_phase":"marketed","molecular_target":"Histamine H4 receptor, Solute carrier family 22 member 2, 5-hydroxytryptamine receptor 2A","drug_class":"First-generation antihistamine, Sedative","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"cetirizine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zyrtec","generic_name":"cetirizine","company_name":"Generic (originally UCB Pharma)","drug_phase":"marketed","molecular_target":"Angiopoietin-1 receptor, Histamine H1 receptor, Potassium voltage-gated channel subfamily H member 2","drug_class":"Second-generation antihistamine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"ephedrine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Akovaz","generic_name":"EPHEDRINE","company_name":"","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"Norepinephrine Releasing Agent","quality_score":52,"revenue":null,"mechanism":"Akovaz works by releasing norepinephrine, a natural chemical in the body that helps to relieve symptoms of respiratory and allergic conditions."},{"drug_id":"tramazoline","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rhinol","generic_name":"TRAMAZOLINE","company_name":"","drug_phase":"phase_2","molecular_target":"Alpha-2A adrenergic receptor","drug_class":"tramazoline","quality_score":null,"revenue":null,"mechanism":"Rhinol works by activating the alpha-2A adrenergic receptor to constrict blood vessels in the nasal passages."},{"drug_id":"xolair","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Xolair","company_name":"Taizhou Mabtech Pharmaceutical Co.,Ltd","drug_phase":"marketed","molecular_target":"Ig epsilon chain C region","drug_class":"","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"patanol","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Patanol","company_name":"ORA, Inc.","drug_phase":"marketed","molecular_target":"Histamine H1 receptor, Histamine H1 receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"desloratadine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Clarinex","generic_name":"desloratadine","company_name":"Generic (originally Schering-Plough/MSD)","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 6, Histamine H4 receptor, Multidrug resistance protein 1","drug_class":"Histamine-1 Receptor Antagonist [EPC]","quality_score":54,"revenue":null,"mechanism":"Active metabolite of loratadine with higher potency at H1 receptors and additional anti-inflammatory properties."},{"drug_id":"loratadine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Claritin","generic_name":"loratadine","company_name":"Generic (originally Schering-Plough)","drug_phase":"marketed","molecular_target":"Sodium-dependent neutral amino acid transporter B(0)AT2, Cytochrome P450 2C19, Multidrug resistance protein 1","drug_class":"Second-generation antihistamine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"promethazine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Phenergan","generic_name":"promethazine","company_name":"Generic (originally Wyeth/Pfizer)","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 6, FAD-linked sulfhydryl oxidase ALR","drug_class":"Phenothiazine antihistamine/antiemetic","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"pseudoephedrine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sudafed","generic_name":"pseudoephedrine","company_name":"Generic (multiple manufacturers)","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor, Alpha-2A adrenergic receptor, Beta-2 adrenergic receptor","drug_class":"Nasal decongestant (sympathomimetic)","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"azelastine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Astelin","generic_name":"AZELASTINE","company_name":"Bayer","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Histamine-1 Receptor Antagonist","quality_score":53,"revenue":null,"mechanism":""},{"drug_id":"dexchlorpheniramine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dexchlorpheniramine Maleate","generic_name":"DEXCHLORPHENIRAMINE","company_name":"","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"dexchlorpheniramine","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chlorphenamine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tussionex Pennkinetic","generic_name":"chlorphenamine","company_name":"Bayer","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Histamine-1 Receptor Antagonist","quality_score":36,"revenue":null,"mechanism":""},{"drug_id":"methylprednisolone-acetate","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Depo-Medrol","generic_name":"METHYLPREDNISOLONE ACETATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":65,"revenue":null,"mechanism":"Depo-Medrol works by binding to the glucocorticoid receptor, which then regulates the expression of genes involved in inflammation and immune response."},{"drug_id":"triprolidine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Actidil","generic_name":"TRIPROLIDINE","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"triprolidine","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"brompheniramine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dimetane-Dx","generic_name":"BROMPHENIRAMINE","company_name":"","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"brompheniramine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"carbinoxamine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Karbinal Er","generic_name":"CARBINOXAMINE","company_name":"Mcneil","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Histamine-1 Receptor Antagonist","quality_score":70,"revenue":null,"mechanism":"Karbinal Er works by blocking the histamine H1 receptor, a key player in the body's allergic response."},{"drug_id":"azatadine","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Azatidine","generic_name":"AZATADINE","company_name":"","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"azatadine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"phenylpropanol","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"phenylpropanol","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"desloratadin","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Desloratadin","company_name":"Max Zeller Soehne AG","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 6, Histamine H4 receptor, Multidrug resistance protein 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prednisone","indication_name":"Seasonal or perennial allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Deltasone","generic_name":"prednisone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"pataday","indication_name":"Seasonal allergic rhinitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pataday","company_name":"Merck Sharp & Dohme LLC","drug_phase":"marketed","molecular_target":"Histamine H1 receptor, Histamine H1 receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":43,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02246920","title":"Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":1474,"lead_sponsor_name":"Teva Pharmaceuticals USA","has_results":true},{"nct_id":"NCT00564421","title":"Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":798,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT00783146","title":"Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":728,"lead_sponsor_name":"Organon and Co","has_results":false},{"nct_id":"NCT00783211","title":"Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR)(Study P04053)(COMPLETED)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":722,"lead_sponsor_name":"Organon and Co","has_results":false},{"nct_id":"NCT05311475","title":"Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic Rhinitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":669,"lead_sponsor_name":"Sandoz","has_results":false},{"nct_id":"NCT06200766","title":"A Multicenter, Randomized, Double-blind, Three-arm, Parallel Clinical Endpoint Bioequivalence Study of Monometasone Furoate Nasal Spray in Patients With Seasonal Allergic Rhinitis","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":640,"lead_sponsor_name":"Zheng Liu ENT","has_results":false},{"nct_id":"NCT07146126","title":"A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Prime Gene Therapeutics Co., Ltd.","has_results":false},{"nct_id":"NCT05540717","title":"Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":555,"lead_sponsor_name":"Allergy Therapeutics","has_results":true},{"nct_id":"NCT07291284","title":"Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic Rhinitis","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":546,"lead_sponsor_name":"Longbio Pharma","has_results":false},{"nct_id":"NCT07055542","title":"Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":530,"lead_sponsor_name":"University of Melbourne","has_results":false},{"nct_id":"NCT05590598","title":"Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Momat Rino Advance, Nasal Spray, 140 mcg + 50 mcg, (Glenmark, India) Administered as a Monotherapy to Patients With Seasonal Allergic Rhinitis.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":472,"lead_sponsor_name":"Sandoz","has_results":false},{"nct_id":"NCT02320396","title":"Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":449,"lead_sponsor_name":"Organon and Co","has_results":true},{"nct_id":"NCT03463031","title":"Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":446,"lead_sponsor_name":"Glenmark Specialty S.A.","has_results":true},{"nct_id":"NCT00423995","title":"Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients Exposed to Pollen in an EEU (Study P04822)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":379,"lead_sponsor_name":"Organon and Co","has_results":false},{"nct_id":"NCT06861101","title":"Phase II Study of JT002 in the Treatment of Seasonal Allergic Rhinitis in Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":370,"lead_sponsor_name":"Shanghai JunTop Biosciences Co., LTD","has_results":false},{"nct_id":"NCT03855189","title":"Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":345,"lead_sponsor_name":"Organon and Co","has_results":true},{"nct_id":"NCT01024608","title":"Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":340,"lead_sponsor_name":"Teva Branded Pharmaceutical Products R&D, Inc.","has_results":true},{"nct_id":"NCT03369704","title":"Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":337,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT02582073","title":"Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":265,"lead_sponsor_name":"Allergy Therapeutics","has_results":false},{"nct_id":"NCT00867191","title":"Comparison of the Effects of Desloratadine and Placebo in the Relief of Nasal Symptom Scores in Subjects With Seasonal Allergic Rhinitis to Cypress Pollen (Study P02836)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":233,"lead_sponsor_name":"Organon and Co","has_results":false},{"nct_id":"NCT01857063","title":"Study of the Efficacy and Safety of MK-0476 in Japanese Pediatric Participants With Seasonal Allergic Rhinitis (MK-0476-519)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"Organon and Co","has_results":true},{"nct_id":"NCT04652245","title":"Dymista Allergen Chamber - Onset of Action Study","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":216,"lead_sponsor_name":"MEDA Pharma GmbH & Co. KG","has_results":true},{"nct_id":"NCT06046391","title":"Efficacy and Safety of LP-003 in Moderate-to-severe Seasonal Allergic Rhinitis Adult","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Longbio Pharma","has_results":false},{"nct_id":"NCT03444506","title":"Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Glenmark Pharmaceuticals Ltd. India","has_results":false},{"nct_id":"NCT06760182","title":"Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":169,"lead_sponsor_name":"Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.","has_results":false},{"nct_id":"NCT03097432","title":"Non-interventional Study to Assess the Tolerability, the Safety Profile and the Adherence of Different Up-dosing Schemes for a Sublingual Immunotherapy Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":164,"lead_sponsor_name":"University Hospital of Cologne","has_results":false},{"nct_id":"NCT06846385","title":"Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":160,"lead_sponsor_name":"Shanghai Mabgeek Biotech.Co.Ltd","has_results":false},{"nct_id":"NCT07052097","title":"Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic Rhinitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":136,"lead_sponsor_name":"Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT00783133","title":"Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03177)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":131,"lead_sponsor_name":"Organon and Co","has_results":false},{"nct_id":"NCT06300203","title":"Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false},{"nct_id":"NCT04815668","title":"Acupuncture at the Sphenopalatine Ganglion in the Treatment of Moderate-to-severe Seasonal Allergic Rhinitis","phase":"NA","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","has_results":false},{"nct_id":"NCT06661252","title":"Evaluation of Nasal Biomarkers for Objective Assessment of Disease Severity in Respiratory Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":111,"lead_sponsor_name":"Diag-Nose Medical Pty Ltd","has_results":false},{"nct_id":"NCT07436234","title":"A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Seasonal Allergic Rhinitis","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":111,"lead_sponsor_name":"Akeso","has_results":false},{"nct_id":"NCT04752956","title":"Effectiveness of Sodium Hyaluronate In Relieving Nasal Symptoms Of Children With Seasonal Allergic Rhinitis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":101,"lead_sponsor_name":"Saglik Bilimleri Universitesi","has_results":false},{"nct_id":"NCT06171074","title":"Study of CM310 in Subjects With Seasonal Allergic Rhinitis","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Keymed Biosciences Co.Ltd","has_results":false},{"nct_id":"NCT05692154","title":"A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic Rhinitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"Opella Healthcare Group SAS, a Sanofi Company","has_results":true},{"nct_id":"NCT04670627","title":"Biomarkers in Nasal Samples of Seasonal Allergic Rhinitics","phase":"","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT06126952","title":"Azelastine Allergen Chamber - Onset of Action Study","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":84,"lead_sponsor_name":"MEDA Pharma GmbH & Co. KG","has_results":false},{"nct_id":"NCT03004131","title":"MP-AzeFlu Allergen Chamber - Onset of Action Study","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"MEDA Pharma GmbH & Co. KG","has_results":false},{"nct_id":"NCT03570957","title":"A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Tanabe Pharma Corporation","has_results":false},{"nct_id":"NCT03649139","title":"Effect and Underlying Immunological Mechanisms of Sublingual Immunotherapy in Allergic Rhinitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false},{"nct_id":"NCT04052945","title":"Efficacy, Safety and Underlying Mechanisms of Sphenopalatine Ganglion Acupuncture for Seasonal Allergic Rhinitis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":70,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false},{"nct_id":"NCT05098522","title":"Allergen Challenge Trial of IRL201104 in Seasonal Allergic Rhinitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"Revolo Biotherapeutics","has_results":false},{"nct_id":"NCT05297760","title":"Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT06180083","title":"Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Humanis Saglık Anonim Sirketi","has_results":false},{"nct_id":"NCT04817800","title":"To Investigate Drug-drug Interaction and Relative Bioavailability Between the FDC AzelastineHCL/Beclomethasone Dipropionate Nasal Spray, & Beclomethasone Dipropionate Nasal Spray in the Test Vehicle, and RinoClenil® Nasal Spray","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Humanis Saglık Anonim Sirketi","has_results":false},{"nct_id":"NCT04622917","title":"Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis.","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT04709614","title":"Psychological Factors That Influence Severity of Allergic Rhinitis","phase":"","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"The University Clinic of Pulmonary and Allergic Diseases Golnik","has_results":false},{"nct_id":"NCT05887843","title":"Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":38,"lead_sponsor_name":"Sandoz","has_results":false},{"nct_id":"NCT04489121","title":"The Efficacy of Preseasonal Omalizumab Treatment","phase":"NA","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}